ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Mueller I, Galinski MR, Baird JK, Carlton JM, 2009. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 9: 555–566.
-
2.
Miller LH, Mason SJ, Clyde DF, McGinniss MH, 1976. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 295: 302–304.
-
3.
Culleton RL, Mita T, Ndounga M, Unger H, Cravo PV, Paganotti GM, Takahashi N, Kaneko A, Eto H, Tinto H, Karema C, D'Alessandro U, do Rosário V, Kobayakawa T, Ntoumi F, Carter R, Tanabe K, 2008. Failure to detect Plasmodium vivax in west and central Africa by PCR species typing. Malar J 7: 174–181.
-
4.
Mendis K, Sina BJ, Marchesini P, Carter R, 2001. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64: 97–106.
-
5.
Gething PW, Elyazar IR, Moyes CL, Smith DL, Battle KE, Guerra CA, Patil AP, Tatem AJ, Howes RE, Myers MF, George DB, Horby P, Wertheim HF, Price RN, Müeller I, Baird JK, Hay SI, 2012. A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis 6: e1814.
-
6.
Odolini S, Gautret P, Parola P, 2012. Epidemiology of imported malaria in the mediterranean region. Mediterr J Hematol Infect Dis 4: e2012031.
-
7.
Calderaro A, Piccolo G, Gorrini C, Rossi S, 2013. Accurate identification of the six human Plasmodium spp. causing imported malaria, including Plasmodium ovale wallikeri and Plasmodium knowlesi. Malar J 12: 321.
-
8.
Whitty CJ, Chiodini PL, Lalloo DG, 2013. Investigation and treatment of imported malaria in non-endemic countries. BMJ 346: f2900.
-
9.
Centers for Disease Control and Prevention, Filler SJ, MacArthur JR, Parise M, Wirtz R, Eliades MJ, Dasilva A, Steketee R, 2006. Locally acquired mosquito-transmitted malaria: a guide for investigations in the United States. MMWR Recomm Rep 55: 1–9.
-
10.
Kruger A, Rech A, Su XZ, Tannich E, 2001. Two cases of autochthonous Plasmodium falciparum malaria in Germany with evidence for local transmission by indigenous Anopheles plumbeus. Trop Med Int Health 6: 983–985.
-
11.
Armengaud A, Legros F, D'Ortenzio E, Quatresous I, Barre H, Houze S, Valayer P, Fanton Y, Schaffner F, 2008. A case of autochthonous Plasmodium vivax malaria, Corsica, August 2006. Travel Med Infect Dis 6: 36–40.
-
12.
Santa-Olalla Peralta P, Vazquez-Torres MC, Latorre-Fandos E, Mairal-Claver P, Cortina-Solano P, Puy-Azón A, Adiego Sancho B, Leitmeyer K, Lucientes-Curdi J, Sierra-Moros MJ, 2010. First autochthonous malaria case due to Plasmodium vivax since eradication, Spain, October. Euro Surveill 15: 19684.
-
13.
Arends JE, Oosterheert JJ, Kraaij-Dirkzwager MM, Kaan JA, Fanoy EB, Haas PJ, Scholte EJ, Kortbeek LM, Sankatsing SU, 2013. Two cases of Plasmodium falciparum malaria in The Netherlands without recent travel to a malaria-endemic country. Am J Trop Med Hyg 89: 527–530.
-
14.
Bruce-Chwatt LJ, de Zulueta J, 1980. The Rise and Fall of Malaria in Europe: A Historico-Epidemiological Study. Oxford, NY: Oxford University Press, 18–25.
-
15.
Vakalis N, 2002. Epidemiological Surveillance of Malaria in Countries of Central and Eastern Europe and Selected Independent States: Greece. Report on a WHO intercountry meeting, June 24–26, 2002, Sofia, Bulgaria. Copenhagen, Denmark: World Health Organization Regional Office for Europe, 10.
-
16.
Kampen H, Proft J, Etti S, Maltezos E, Pagonaki M, Maier WA, Seitz HM, 2003. Individual cases of autochthonous malaria in Evros Province, northern Greece: entomological aspects. Parasitol Res 89: 252–258.
-
17.
HPA reports 22 percent increase in malaria cases returning from the Indian sub-continent. Available at: http://webarchive.nationalarchives.gov.uk/20140714084352/http://www.hpa.org.uk/NewsCentre/NationalPressReleases/2012PressReleases/120425Malaria/. Accessed March 6, 2015.
-
18.
Stark K, Schöneberg I, 2012. Increase in malaria cases imported from Pakistan to Germany in 2012. Euro Surveill 17: 20320.
-
19.
Vakali A, Patsoula E, Spanakos G, Danis K, Vassalou E, Tegos N, Economopoulou A, Baka A, Pavli A, Koutis C, Hadjichristodoulou C, Kremastinou T, 2012. Malaria in Greece, 1975 to 2010. Euro Surveill 17: 20322.
-
20.
Danis K, Lenglet A, Tseroni M, Baka A, Tsiodras S, Bonovas S, 2013. Malaria in Greece: historical and current reflections on a re-emerging vector borne disease. Travel Med Infect Dis 11: 8–14.
-
21.
Struik SS, Riley EM, 2004. Does malaria suffer from lack of memory? Immunol Rev 201: 268–290.
-
22.
Langhorne J, Ndungu FM, Sponaas AM, Marsh K, 2008. Immunity to malaria: more questions than answers. Nat Immunol 9: 725–732.
-
23.
Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, Carneiro I, Malima R, Lusingu J, Manjurano A, Nkya WM, Lemnge MM, Cox J, Reyburn H, Riley EM, 2005. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci USA 102: 5108–5113.
-
24.
Del Giudice G, Lambert PH, Mendis K, Pessi A, Pessi A, Tanner M, 1990. Antibody responses to Plasmodium falciparum and P. vivax sporozoites in areas with stable and unstable malaria. Bull World Health Organ 68: 191–196.
-
25.
Mueller I, Galinski MR, Tsuboi T, Arevalo-Herrera M, 2013. Natural acquisition of immunity to Plasmodium vivax: epidemiological observations and potential targets. Adv Parasitol 81: 77–131.
-
26.
Nardone A, Miller E, 2004. Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2). Eurosurveillance 9: 4.
-
27.
Doderer C, Heschung A, Guntz P, Cazenave JP, Hansmann Y, Senegas A, Pfaff AW, Abdelrahman T, Candolfi E, 2007. A new ELISA kit which uses a combination of Plasmodium falciparum extract and recombinant Plasmodium vivax antigens as an alternative to IFAT for detection of malaria antibodies. Malar J 97: 557–564.
-
28.
Collins WE, Jeffery GM, Skinner JC, 1964. Fluorescent antibody studies in human malaria. I. Development of antibodies to Plasmodium malariae. Am J Trop Med Hyg 13: 1–5.
-
29.
Baird JK, Barcus MJ, Elyazar IR, Bangs MJ, Maguire JD, Fryauff DJ, Richie TL, Sekartuti, Kalalo W, 2003. Onset of clinical immunity to Plasmodium falciparum among Japanese migrants to Indonesian Papua. Ann Trop Med Parasitol 97: 557–564.
-
30.
Park CG, Chwae YJ, Kim JI, Lee JH, Hur GM, Jeon BH, Koh JS, Han JH, Lee SJ, Park JW, Kaslow DC, Strickman D, Roh CS, 2000. Serologic responses of Korean soldiers serving in malaria-endemic areas during a recent outbreak of Plasmodium vivax. Am J Trop Med Hyg 62: 720–725.
-
31.
Bruce-Chwatt LJ, Draper CC, Avramidis D, Kazandzoglou O, 1975. Sero-epidemiological surveillance of disappearing malaria in Greece. J Trop Med Hyg 78: 194–200.
-
32.
Drakeley C, Cook J, 2009. Chapter 5. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives. Adv Parasitol 69: 299–352.
-
33.
Cavanagh DR, Elhassan IM, Roper C, Robinson VJ, Giha H, Holder AA, Hviid L, Theander TG, Arnot DE, McBride JS, 1998. A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. J Immunol 161: 347–359.
-
34.
Kinyanjui SM, Bull P, Newbold CI, Marsh K, 2003. Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens. J Infect Dis 187: 667–674.
-
35.
Asito AS, Moormann AM, Kiprotich C, Ng'ang'a ZW, Ploutz-Snyder R, Rochford R, 2008. Alterations on peripheral B cell subsets following an acute uncomplicated clinical malaria infection in children. Malar J 7: 238.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 194 | 173 | 15 |
| Full Text Views | 291 | 10 | 0 |
| PDF Downloads | 60 | 4 | 0 |
Assessment of Antibody Responses in Local and Immigrant Residents of Areas with Autochthonous Malaria Transmission in Greece
Evangelia-Theofano Piperaki
Evangelia-Theofano Piperaki
Department of Microbiology, Medical School, University of Athens, Athens, Greece; Hellenic Center for Disease Control and Prevention (HCDCP), Athens, Greece; General Hospital of Sparti, Sparti, Greece; Department of Hygiene and Epidemiology, Medical School, University of Thessaly, Larissa, Greece
Search for other papers by Evangelia-Theofano Piperaki in
Current site
Google Scholar
PubMed
Search for other papers by Evangelia-Theofano Piperaki in
Current site
Google Scholar
PubMed
Maria Mavrouli
Maria Mavrouli
Department of Microbiology, Medical School, University of Athens, Athens, Greece; Hellenic Center for Disease Control and Prevention (HCDCP), Athens, Greece; General Hospital of Sparti, Sparti, Greece; Department of Hygiene and Epidemiology, Medical School, University of Thessaly, Larissa, Greece
Search for other papers by Maria Mavrouli in
Current site
Google Scholar
PubMed
Search for other papers by Maria Mavrouli in
Current site
Google Scholar
PubMed
Maria Tseroni
Maria Tseroni
Department of Microbiology, Medical School, University of Athens, Athens, Greece; Hellenic Center for Disease Control and Prevention (HCDCP), Athens, Greece; General Hospital of Sparti, Sparti, Greece; Department of Hygiene and Epidemiology, Medical School, University of Thessaly, Larissa, Greece
Search for other papers by Maria Tseroni in
Current site
Google Scholar
PubMed
Search for other papers by Maria Tseroni in
Current site
Google Scholar
PubMed
John Routsias
John Routsias
Department of Microbiology, Medical School, University of Athens, Athens, Greece; Hellenic Center for Disease Control and Prevention (HCDCP), Athens, Greece; General Hospital of Sparti, Sparti, Greece; Department of Hygiene and Epidemiology, Medical School, University of Thessaly, Larissa, Greece
Search for other papers by John Routsias in
Current site
Google Scholar
PubMed
Search for other papers by John Routsias in
Current site
Google Scholar
PubMed
Athina Kallimani
Athina Kallimani
Department of Microbiology, Medical School, University of Athens, Athens, Greece; Hellenic Center for Disease Control and Prevention (HCDCP), Athens, Greece; General Hospital of Sparti, Sparti, Greece; Department of Hygiene and Epidemiology, Medical School, University of Thessaly, Larissa, Greece
Search for other papers by Athina Kallimani in
Current site
Google Scholar
PubMed
Search for other papers by Athina Kallimani in
Current site
Google Scholar
PubMed
Lamprini Veneti
Lamprini Veneti
Department of Microbiology, Medical School, University of Athens, Athens, Greece; Hellenic Center for Disease Control and Prevention (HCDCP), Athens, Greece; General Hospital of Sparti, Sparti, Greece; Department of Hygiene and Epidemiology, Medical School, University of Thessaly, Larissa, Greece
Search for other papers by Lamprini Veneti in
Current site
Google Scholar
PubMed
Search for other papers by Lamprini Veneti in
Current site
Google Scholar
PubMed
Maria Georgitsou
Maria Georgitsou
Department of Microbiology, Medical School, University of Athens, Athens, Greece; Hellenic Center for Disease Control and Prevention (HCDCP), Athens, Greece; General Hospital of Sparti, Sparti, Greece; Department of Hygiene and Epidemiology, Medical School, University of Thessaly, Larissa, Greece
Search for other papers by Maria Georgitsou in
Current site
Google Scholar
PubMed
Search for other papers by Maria Georgitsou in
Current site
Google Scholar
PubMed
Maria Chania
Maria Chania
Department of Microbiology, Medical School, University of Athens, Athens, Greece; Hellenic Center for Disease Control and Prevention (HCDCP), Athens, Greece; General Hospital of Sparti, Sparti, Greece; Department of Hygiene and Epidemiology, Medical School, University of Thessaly, Larissa, Greece
Search for other papers by Maria Chania in
Current site
Google Scholar
PubMed
Search for other papers by Maria Chania in
Current site
Google Scholar
PubMed
Theano Georgakopoulou
Theano Georgakopoulou
Department of Microbiology, Medical School, University of Athens, Athens, Greece; Hellenic Center for Disease Control and Prevention (HCDCP), Athens, Greece; General Hospital of Sparti, Sparti, Greece; Department of Hygiene and Epidemiology, Medical School, University of Thessaly, Larissa, Greece
Search for other papers by Theano Georgakopoulou in
Current site
Google Scholar
PubMed
Search for other papers by Theano Georgakopoulou in
Current site
Google Scholar
PubMed
Christos Hadjichristodoulou
Christos Hadjichristodoulou
Department of Microbiology, Medical School, University of Athens, Athens, Greece; Hellenic Center for Disease Control and Prevention (HCDCP), Athens, Greece; General Hospital of Sparti, Sparti, Greece; Department of Hygiene and Epidemiology, Medical School, University of Thessaly, Larissa, Greece
Search for other papers by Christos Hadjichristodoulou in
Current site
Google Scholar
PubMed
Search for other papers by Christos Hadjichristodoulou in
Current site
Google Scholar
PubMed
Athanassios Tsakris
Athanassios Tsakris
Department of Microbiology, Medical School, University of Athens, Athens, Greece; Hellenic Center for Disease Control and Prevention (HCDCP), Athens, Greece; General Hospital of Sparti, Sparti, Greece; Department of Hygiene and Epidemiology, Medical School, University of Thessaly, Larissa, Greece
Search for other papers by Athanassios Tsakris in
Current site
Google Scholar
PubMed
Search for other papers by Athanassios Tsakris in
Current site
Google Scholar
PubMed
Greece has been officially malaria free since 1974. However, from 2009 to 2012, several locally acquired, cases of Plasmodium vivax malaria were detected, in immigrants and in Greek citizens. In this study, the antibody (Ab) response of Greeks and immigrants with documented malaria was initially assessed, followed by an Ab screening of Greeks and immigrant residents of local transmission areas. Of the 38 patients tested, 10.5% of Greeks and 15.7% of immigrants were positive 5–7 months after infection. Of the 1,019 individuals from various areas of Greece, including those of autochthonous transmission, 85 of the 721 (11.8%) immigrants were positive, whereas all 298 Greeks were negative. The rapid Ab titer decline observed is reasonable, given the non-endemic epidemiological setting. The seroepidemiological findings indicate that the local Greek population remains malaria naive and that at this point Greeks are unlikely to serve as reservoir for the infection of local mosquitoes.
Author Notes
Financial support: The study was conducted in the context of the integrated surveillance and control program for West Nile Virus and malaria in Greece (MALWEST Project), which is implemented through the Operational Program entitled “Human Resources Development” of National Strategic Reference Framework” (NSRF) 2007–2013. The program is co-funded by Greece and the European Union—European Regional Development Fund.
Authors' addresses: Evangelia-Theofano Piperaki, Maria Mavrouli, John Routsias, and Athanassios Tsakris, Department of Microbiology, Medical School, University of Athens, Greece, E-mails: epiper@med.uoa.gr, mmavrouli@med.uoa.gr, jroutsias@med.uoa.gr, and atsakris@med.uoa.gr. Maria Tseroni, Athina Kallimani, Lamprini Veneti, and Theano Georgakopoulou, Hellenic Center for Disease Control and Prevention (HCDCP), Athens, Greece, E-mails: tseroni@keelpno.gr, akalliman@yahoo.gr, veneti@keelpno.gr, and georgakopoulou@keelpno.gr. Maria Georgitsou and Maria Chania, General Hospital of Sparti, Sparti, Greece, E-mails: pmas42@otenet.gr and mchania8@gmail.com. Christos Hadjichristodoulou, Laboratory of Hygiene and Epidemiology, Medical School, University of Thessaly, Larissa, Greece, E-mail: xhatzi@med.uth.gr.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Mueller I, Galinski MR, Baird JK, Carlton JM, 2009. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 9: 555–566.
-
2.
Miller LH, Mason SJ, Clyde DF, McGinniss MH, 1976. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 295: 302–304.
-
3.
Culleton RL, Mita T, Ndounga M, Unger H, Cravo PV, Paganotti GM, Takahashi N, Kaneko A, Eto H, Tinto H, Karema C, D'Alessandro U, do Rosário V, Kobayakawa T, Ntoumi F, Carter R, Tanabe K, 2008. Failure to detect Plasmodium vivax in west and central Africa by PCR species typing. Malar J 7: 174–181.
-
4.
Mendis K, Sina BJ, Marchesini P, Carter R, 2001. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64: 97–106.
-
5.
Gething PW, Elyazar IR, Moyes CL, Smith DL, Battle KE, Guerra CA, Patil AP, Tatem AJ, Howes RE, Myers MF, George DB, Horby P, Wertheim HF, Price RN, Müeller I, Baird JK, Hay SI, 2012. A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis 6: e1814.
-
6.
Odolini S, Gautret P, Parola P, 2012. Epidemiology of imported malaria in the mediterranean region. Mediterr J Hematol Infect Dis 4: e2012031.
-
7.
Calderaro A, Piccolo G, Gorrini C, Rossi S, 2013. Accurate identification of the six human Plasmodium spp. causing imported malaria, including Plasmodium ovale wallikeri and Plasmodium knowlesi. Malar J 12: 321.
-
8.
Whitty CJ, Chiodini PL, Lalloo DG, 2013. Investigation and treatment of imported malaria in non-endemic countries. BMJ 346: f2900.
-
9.
Centers for Disease Control and Prevention, Filler SJ, MacArthur JR, Parise M, Wirtz R, Eliades MJ, Dasilva A, Steketee R, 2006. Locally acquired mosquito-transmitted malaria: a guide for investigations in the United States. MMWR Recomm Rep 55: 1–9.
-
10.
Kruger A, Rech A, Su XZ, Tannich E, 2001. Two cases of autochthonous Plasmodium falciparum malaria in Germany with evidence for local transmission by indigenous Anopheles plumbeus. Trop Med Int Health 6: 983–985.
-
11.
Armengaud A, Legros F, D'Ortenzio E, Quatresous I, Barre H, Houze S, Valayer P, Fanton Y, Schaffner F, 2008. A case of autochthonous Plasmodium vivax malaria, Corsica, August 2006. Travel Med Infect Dis 6: 36–40.
-
12.
Santa-Olalla Peralta P, Vazquez-Torres MC, Latorre-Fandos E, Mairal-Claver P, Cortina-Solano P, Puy-Azón A, Adiego Sancho B, Leitmeyer K, Lucientes-Curdi J, Sierra-Moros MJ, 2010. First autochthonous malaria case due to Plasmodium vivax since eradication, Spain, October. Euro Surveill 15: 19684.
-
13.
Arends JE, Oosterheert JJ, Kraaij-Dirkzwager MM, Kaan JA, Fanoy EB, Haas PJ, Scholte EJ, Kortbeek LM, Sankatsing SU, 2013. Two cases of Plasmodium falciparum malaria in The Netherlands without recent travel to a malaria-endemic country. Am J Trop Med Hyg 89: 527–530.
-
14.
Bruce-Chwatt LJ, de Zulueta J, 1980. The Rise and Fall of Malaria in Europe: A Historico-Epidemiological Study. Oxford, NY: Oxford University Press, 18–25.
-
15.
Vakalis N, 2002. Epidemiological Surveillance of Malaria in Countries of Central and Eastern Europe and Selected Independent States: Greece. Report on a WHO intercountry meeting, June 24–26, 2002, Sofia, Bulgaria. Copenhagen, Denmark: World Health Organization Regional Office for Europe, 10.
-
16.
Kampen H, Proft J, Etti S, Maltezos E, Pagonaki M, Maier WA, Seitz HM, 2003. Individual cases of autochthonous malaria in Evros Province, northern Greece: entomological aspects. Parasitol Res 89: 252–258.
-
17.
HPA reports 22 percent increase in malaria cases returning from the Indian sub-continent. Available at: http://webarchive.nationalarchives.gov.uk/20140714084352/http://www.hpa.org.uk/NewsCentre/NationalPressReleases/2012PressReleases/120425Malaria/. Accessed March 6, 2015.
-
18.
Stark K, Schöneberg I, 2012. Increase in malaria cases imported from Pakistan to Germany in 2012. Euro Surveill 17: 20320.
-
19.
Vakali A, Patsoula E, Spanakos G, Danis K, Vassalou E, Tegos N, Economopoulou A, Baka A, Pavli A, Koutis C, Hadjichristodoulou C, Kremastinou T, 2012. Malaria in Greece, 1975 to 2010. Euro Surveill 17: 20322.
-
20.
Danis K, Lenglet A, Tseroni M, Baka A, Tsiodras S, Bonovas S, 2013. Malaria in Greece: historical and current reflections on a re-emerging vector borne disease. Travel Med Infect Dis 11: 8–14.
-
21.
Struik SS, Riley EM, 2004. Does malaria suffer from lack of memory? Immunol Rev 201: 268–290.
-
22.
Langhorne J, Ndungu FM, Sponaas AM, Marsh K, 2008. Immunity to malaria: more questions than answers. Nat Immunol 9: 725–732.
-
23.
Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, Carneiro I, Malima R, Lusingu J, Manjurano A, Nkya WM, Lemnge MM, Cox J, Reyburn H, Riley EM, 2005. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci USA 102: 5108–5113.
-
24.
Del Giudice G, Lambert PH, Mendis K, Pessi A, Pessi A, Tanner M, 1990. Antibody responses to Plasmodium falciparum and P. vivax sporozoites in areas with stable and unstable malaria. Bull World Health Organ 68: 191–196.
-
25.
Mueller I, Galinski MR, Tsuboi T, Arevalo-Herrera M, 2013. Natural acquisition of immunity to Plasmodium vivax: epidemiological observations and potential targets. Adv Parasitol 81: 77–131.
-
26.
Nardone A, Miller E, 2004. Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2). Eurosurveillance 9: 4.
-
27.
Doderer C, Heschung A, Guntz P, Cazenave JP, Hansmann Y, Senegas A, Pfaff AW, Abdelrahman T, Candolfi E, 2007. A new ELISA kit which uses a combination of Plasmodium falciparum extract and recombinant Plasmodium vivax antigens as an alternative to IFAT for detection of malaria antibodies. Malar J 97: 557–564.
-
28.
Collins WE, Jeffery GM, Skinner JC, 1964. Fluorescent antibody studies in human malaria. I. Development of antibodies to Plasmodium malariae. Am J Trop Med Hyg 13: 1–5.
-
29.
Baird JK, Barcus MJ, Elyazar IR, Bangs MJ, Maguire JD, Fryauff DJ, Richie TL, Sekartuti, Kalalo W, 2003. Onset of clinical immunity to Plasmodium falciparum among Japanese migrants to Indonesian Papua. Ann Trop Med Parasitol 97: 557–564.
-
30.
Park CG, Chwae YJ, Kim JI, Lee JH, Hur GM, Jeon BH, Koh JS, Han JH, Lee SJ, Park JW, Kaslow DC, Strickman D, Roh CS, 2000. Serologic responses of Korean soldiers serving in malaria-endemic areas during a recent outbreak of Plasmodium vivax. Am J Trop Med Hyg 62: 720–725.
-
31.
Bruce-Chwatt LJ, Draper CC, Avramidis D, Kazandzoglou O, 1975. Sero-epidemiological surveillance of disappearing malaria in Greece. J Trop Med Hyg 78: 194–200.
-
32.
Drakeley C, Cook J, 2009. Chapter 5. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives. Adv Parasitol 69: 299–352.
-
33.
Cavanagh DR, Elhassan IM, Roper C, Robinson VJ, Giha H, Holder AA, Hviid L, Theander TG, Arnot DE, McBride JS, 1998. A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. J Immunol 161: 347–359.
-
34.
Kinyanjui SM, Bull P, Newbold CI, Marsh K, 2003. Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens. J Infect Dis 187: 667–674.
-
35.
Asito AS, Moormann AM, Kiprotich C, Ng'ang'a ZW, Ploutz-Snyder R, Rochford R, 2008. Alterations on peripheral B cell subsets following an acute uncomplicated clinical malaria infection in children. Malar J 7: 238.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 194 | 173 | 15 |
| Full Text Views | 291 | 10 | 0 |
| PDF Downloads | 60 | 4 | 0 |